Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prevention of Stroke.

Michael D. Ezekowitz1

  • 1Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT.

The American Journal of Geriatric Cardiology
|June 21, 2001
PubMed
Summary
This summary is machine-generated.

Elderly patients with atrial fibrillation (AF) face high stroke risks. Anticoagulation, particularly warfarin, offers substantial stroke protection in eligible older adults when managed correctly.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial Fibrillation in the Elderly.

The American journal of geriatric cardiology·2001
Same author

Executive Summary: Pivotal Research in Cardiovascular Syndromes in the Elderly.

The American journal of geriatric cardiology·2001
See all related articles

Area of Science:

  • Cardiology
  • Geriatrics
  • Neurology

Background:

  • Atrial fibrillation (AF) increases stroke risk, especially in the elderly.
  • Comorbidities like hypertension, diabetes, and poor ventricular function further elevate risk.
  • Previous transient ischemic attack (TIA) or stroke history is a significant risk factor.

Purpose of the Study:

  • To review stroke risk stratification in atrial fibrillation patients.
  • To evaluate anticoagulation benefits and alternatives in elderly AF patients.
  • To define optimal management targets for anticoagulation therapy.

Main Methods:

  • Literature review of stroke risk factors in atrial fibrillation.
  • Analysis of anticoagulation efficacy and safety data.

Related Experiment Videos

  • Evaluation of alternative antiplatelet therapies.

    • Main Results:

    • Elderly patients with AF have a significantly higher risk of stroke.
    • Anticoagulation with warfarin, targeting an International Normalized Ratio (INR) of 2.0-3.5, provides substantial benefit.
    • Well-controlled blood pressure is crucial for effective anticoagulation.
    • Aspirin (325 mg) is an alternative for those unable to use anticoagulants but offers less protection.

    Conclusions:

    • Anticoagulation is recommended for eligible elderly patients with atrial fibrillation.
    • Optimal INR and blood pressure control are essential for maximizing warfarin's benefits.
    • Aspirin serves as a less effective alternative when anticoagulation is contraindicated.